Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Small Cell Lung Cancer
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Biological, Procedure, Drug, Device
Participants:
27
Start Date:
June 30, 2022
Phase II Study of a Personalized Neoantigen Vaccine in Combination With Durvalumab (MEDI4736) in Extensive Stage Small Cell Lung Cancer
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 3
Intervention Type:
Radiation
Participants:
600
Start Date:
September 2021
PRophylactic Cerebral Irradiation or Active MAgnetic Resonance Imaging Surveillance in Small-cell Lung Cancer Patients (PRIMALung Study)
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug, Other
Participants:
363
Start Date:
July 15, 2021
A Multicenter, Double-Blind, Placebo-Controlled, Randomized, Phase 2 Study to Investigate the Efficacy and Safety of Atezolizumab or Atezolizumab + Tiragolumab as Consolidation Therapy in Patients With Limited Stage Small Cell Lung Cancer Who Have Not Progressed After Chemoradiotherapy
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Drug
Participants:
20
Start Date:
May 6, 2021
A Phase II, Open, Single-center Study of PD-1 Antibody and PARP Inhibitor as Consolidation Treatment for Patients With Extensive Stage Small Cell Lung Cancer Who Have Not Progressed After First-line Treatment
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug, Radiation
Participants:
46
Start Date:
May 2021
Thoracic Radiotherapy Plus Maintenance Durvalumab After First Line Carboplatin and Etoposide Plus Durvalumab in Extensive-stage Disease Small Cell Lung Cancer (ED-SCLC). A Multicenter Single Arm Open Label Phase II Trial.
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug, Biological
Participants:
28
Start Date:
May 1, 2021
A Phase II Trial of Lamivudine in Combination With Chemoimmunotherapy in Patients With Extensive Stage SCLC
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug, Procedure
Participants:
25
Start Date:
May 1, 2021
A Phase II Study of a Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia (ALL) Incorporating Inotuzumab Ozogamicin (InO)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
120
Start Date:
April 20, 2021
Durvalumab+ Anlotinib + Standard Chemotherapy in First-line Treatment of Extensive Small-cell Lung Cancer: a Single-arm, Single-center, Phase II Clinical Study
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
141
Start Date:
April 12, 2021
Efficacy of Spartalizumab Across Multiple Cancer-types in Patients With PD1-high mRNA Expressing Tumors Defined by a Single and Pre-specified Cutoff
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
69
Start Date:
April 1, 2021
A Single -Arm, Open-label, Multicenter Phase II Study of Camrelizumab Combined With Apatinib ,Carboplatin and Etoposide in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC)
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
71
Start Date:
April 1, 2021
an Single Arm, Single Center Phase II Clinical Study of Shr-1210 Combined With Paclitaxel-albumin and Carboplatin in the First-line Treatment of Extensive Stage Small Cell Lung Cancer
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1/Phase 2
Intervention Type:
Drug, Biological
Participants:
142
Start Date:
March 31, 2021
A Phase 1b/2 Multiple-Dose Study to Evaluate the Safety and Efficacy of XmAb18087 ± Pembrolizumab in Subjects With Advanced Merkel Cell Carcinoma or Extensive-stage Small Cell Lung Cancer (DUET-1-02) Protocol
Showing 1-12 of 301
Next